20 Healthcare Stocks Moving In Friday's Pre-Market Session

Gainers

• Tetraphase Pharmaceutical, Inc. TTPH stock moved upwards by 62.20% to $2.66 during Friday's pre-market session. According to the most recent rating by Gabelli & Co., on Mar 17, the current rating is at Sell.

• Aurora Cannabis, Inc. ACB shares rose 29.50% to $8.56. The most recent rating by Piper Sandler, on May 15, is at Neutral, with a price target of $10.

• Hancock Jaffe, Inc. HJLI stock rose 20.69% to $0.42.

• Digirad, Inc. DRAD stock increased by 19.54% to $3.12.

• Caladrius Biosciences, Inc. CLBS shares moved upwards by 14.71% to $1.95.

• Titan Pharmaceuticals, Inc. TTNP stock increased by 14.67% to $0.39.

• Obalon Therapeutics, Inc. OBLN shares increased by 14.29% to $0.96.

• IMAC Holdings, Inc. IMAC shares increased by 13.64% to $1.75. According to the most recent rating by Ascendiant Capital, on Apr 15, the current rating is at Buy.

• Advaxis, Inc. ADXS shares moved upwards by 12.62% to $0.79.

• Sorrento Therapeutics, Inc. SRNE shares increased by 10.31% to $2.89. The most recent rating by H.C. Wainwright, on Mar 30, is at Buy, with a price target of $24.

Losers

• Co-Diagnostics, Inc. CODX stock declined 17.31% to $18.30 during Friday's pre-market session. According to the most recent rating by Maxim Group, on Mar 3, the current rating is at Hold.

• Genfit, Inc. GNFT shares decreased by 16.17% to $5.60. The most recent rating by HC Wainwright & Co., on May 12, is at Neutral, with a price target of $11.

• Covetrus, Inc. CVET stock decreased by 8.56% to $10.25. The most recent rating by Credit Suisse, on Apr 23, is at Neutral, with a price target of $10.

• Helius Medical, Inc. HSDT shares decreased by 6.49% to $0.49.

• Pulmatrix, Inc. PULM shares decreased by 6.25% to $1.50.

• Heat Biologics, Inc. HTBX stock fell 6.05% to $0.56.

• CHF Solutions, Inc. CHFS stock declined 5.85% to $0.32.

• ThermoGenesis Holdings, Inc. THMO stock declined 5.52% to $10.45. The most recent rating by H.C. Wainwright, on Apr 17, is at Buy, with a price target of $10.

• Predictive Oncology, Inc. POAI shares declined 5% to $1.33.

• Bionano Genomics, Inc. BNGO shares declined 4.98% to $0.38. The most recent rating by Oppenheimer, on Apr 8, is at Outperform, with a price target of $2.